Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Proprietary Prodrugs
100,0
%
| 10 | 100,0 % | 27 | 100,0 % | +162,58 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States and Europe
100,0
%
| 10 | 100,0 % | 27 | 100,0 % | +162,58 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 30/10/06 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 10/10/23 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 01/04/15 |
Daniel Gallo
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/23 |
Adrian Quartel
CTO | Chief Tech/Sci/R&D Officer | 63 | 04/01 |
Sven Guenther
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/07 |
Nichol Ochsner
IRC | Investor Relations Contact | - | 09/08/22 |
Abbi Maher
LAW | General Counsel | - | 31/01/23 |
Joshua Schafer
PRN | Corporate Officer/Principal | 53 | 09/01/23 |
Comptroller/Controller/Auditor | 40 | 13/02/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 25/04/23 |
Tamara Favorito
CHM | Chairman | 65 | 18/08/21 |
Douglas Calder
BRD | Director/Board Member | 56 | 25/04/23 |
Christal Mickle
FOU | Founder | 45 | 30/10/06 |
Sven Guenther
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/07 |
Corey Watton
BRD | Director/Board Member | 54 | 25/04/23 |
John Bode
BRD | Director/Board Member | 49 | 25/04/23 |
Thomas Anderson
BRD | Director/Board Member | 68 | 07/08/23 |
Alvin Shih
BRD | Director/Board Member | 47 | 20/01 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 10/10/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 43 429 186 | 38 344 206 ( 88,29 %) | 1 575 692 ( 3,628 %) | 88,29 % |
Coordonnées société
Zevra Therapeutics, Inc.
1180 Celebration Boulevard Suite 103
34747, Celebration
+321 939 3416
http://zevra.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+7,95 % | 72,21 Md | |
+14,98 % | 9,14 Md | |
-24,60 % | 4,33 Md | |
+15,26 % | 4,28 Md | |
+28,46 % | 4,15 Md | |
+7,76 % | 2,19 Md | |
-35,98 % | 1,98 Md | |
+7,76 % | 1,98 Md | |
-47,71 % | 1,68 Md |